Health Care

Torrent Pharma on Wednesday said its consolidated net profit increased by 14 per cent to INR 283 crore in the…

Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY23 Earnings Concall dated Jan. 25, 2023 Corporate Participants: Sudhir Menon -- Executive Director, (Finance) and…

Cipla Limited (NSE: CIPLA) Q3 FY23 Earnings Concall dated Jan. 25, 2023 Corporate Participants: Ankit Bhembre -- Investor Relations Ashish Adukia -- Global Chief…

Dr. Reddy's Laboratories (NSE: DRREDDY) is an Indian multinational pharmaceutical company. Founded in 1984, the company primarily develops and sells…

Indoco Remedies Limited (NSE: INDOCO) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Aditi Panandikar -- Managing Director Sundeep V.…

Granules India Ltd (NSE: GRANULES) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Irfan Raeen -- Investor Relation Advisor Krishna…

Syngene International Ltd (NSE: SYNGENE) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Avantika Mishra -- Associate - EY Jonathan…

Syngene International reported a 5.5% rise in consolidated net profit to INR 109.70 crore in Q3 FY23 as against INR104…

Syngene International Ltd  (NSE: SYNGENE) Q3 FY23 Earnings Concall dated January 24, 2023 Corporate Participants: Avantika Mishra -- Associate - EY Jonathan…

Key highlights from Gland Pharma Limited (GLAND) Q3 FY23 Earnings Concall Management Update: [00:06:08] GLAND said the insulin line is…

Syngene International reported a 5.5% rise in consolidated net profit to INR 109.70 crore in Q3 FY23 as against INR104…

Gland Pharma Limited (NSE:GLAND) Q3 FY23 Earnings Concall dated Jan. 23, 2023. Corporate Participants: Sumanta Bajpayee -- Vice President, Finance and Investor…

SBI LIFE INSURANCE CO LTD (NSE: SBILIFE) Q3 FY23 Earnings Concall dated Jan. 21, 2023 Corporate Participants: Mahesh Kumar Sharma -- Managing…

Shalby Ltd.‘s revenues in Q3FY23 rose 25% to ₹ 2,067 millions. Consolidated Profit After Tax came at ₹ 153 millions…

Shalby Ltd. is a leading chain of multispecialty hospitals and tertiary care centers in India. In the Hospital business, the company…

“Our hospital business is on a very strong growth trajectory and will continue to grow. We will improve not only…

Marksans Pharma (NSE:MARKSANS) is a mid-sized pharmaceutical company with a large presence in the US, UK, Australia, and New Zealand…

“The second quarter saw a healthy improvement in the demand for Non-COVID business across all segments. The Company managed to…

Shalby Ltd.‘s revenues in Q2FY23 rose 11% to ₹ 2,018 millions. Consolidated Profit After Tax came at ₹ 184 millions…

“With all key strategies in place, our team is extremely committed to flawless execution of these strategies. Shalby is very…

Would you buy the stocks of the company that is loaded in debt, entangled in legal battles and generating crores…